#1 Clinical Trials Search in Europe

Explore popular drugs in clinical trials

Check which drugs are currently being frequently studied.

See also our rare diseases glossary and popular diseases list.

Starting by letter

To open the drugs glossary, select a letter from the list below.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All drugs

Most popular drugs

The list below features the most popular substances currently involved in ongoing clinical trials.

Drug trials
Pembrolizumab 441
Sodium Chloride 403
Carboplatin 329
Cisplatin 274
Paclitaxel 245
Fluorouracil 226
Oxaliplatin 218
Nivolumab 205
Dexamethasone 203
Rituximab 189
Cyclophosphamide 183
Durvalumab 157
Bevacizumab 157
Paracetamol 154
Capecitabine 152
Atezolizumab 145
Docetaxel 127
Prednisone 125
Tocilizumab 120
Prednisolone 116
Gemcitabine 114
Venetoclax 113
Etoposide 113
Mycophenolate Mofetil 111
Pemetrexed 109
Doxorubicin Hydrochloride 104
Lenalidomide 97
Infliximab 93
Ipilimumab 89
Acetylsalicylic Acid 87
Folinic Acid 87
Semaglutide 86
Placebo 83
Paclitaxel Albumin-Bound 81
Methotrexate 77
Cytarabine 77
Daratumumab 77
Fludarabine Phosphate 75
Calcium Folinate 74
Letrozole 73
Bortezomib 70
Olaparib 70
Gemcitabine Hydrochloride 68
Dapagliflozin 66
Obinutuzumab 65
Trastuzumab 65
Azacitidine 65
Fulvestrant 62
Cetuximab 61
Tacrolimus 61
Methylprednisolone 61
Lenvatinib 60
Irinotecan 58
Irinotecan Hydrochloride Trihydrate 58
Vincristine Sulfate 57
Temozolomide 56
Cemiplimab 54
Trastuzumab Deruxtecan 53
Enzalutamide 51
Apixaban 49
Dexamethasone Sodium Phosphate 49
Codeine Phosphate 48
Betamethasone Sodium Phosphate 48
Lidocaine Hydrochloride Monohydrate 47
Exemestane 47
Buclizine Hydrochloride 46
Anastrozole 46
Potassium Chloride 46
Empagliflozin 46
Hydrocortisone 45
Lidocaine Hydrochloride 45
Amoxicillin 44
Ribociclib 44
Doxorubicin 43
Pertuzumab 43
Adalimumab 43
Clopidogrel 42
Ruxolitinib 41
Tenofovir Alafenamide 41
Rivaroxaban 41
Abemaciclib 41
Ibrutinib 40
Oxygen 40
Pomalidomide 40
Clavulanic Acid 39
Atorvastatin 39
Ropivacaine Hydrochloride 39
Metformin Hydrochloride 39
Ifosfamide 38
Carfilzomib 38
Palbociclib 38
Propofol 38
Bendamustine Hydrochloride 38
Emtricitabine 37
Acalabrutinib 37
Dostarlimab 37
Cyclophosphamide Monohydrate 37
Pemetrexed Disodium 37
Dexamethasone Phosphate 36
Sulfamethoxazole 36

New drugs in trials

The list below features the new substances involved to ongoing clinical trials.

#1 AZD0120

Clinical trials are investigating AZD0120 in people with relapsed or refractory multiple myeloma, a cancer that has returned or no longer responds to treatment.

1 week ago
#2 STREPTOCOCCUS VIRIDANS

Clinical trials investigating "STREPTOCOCCUS VIRIDANS" are studying whether a related study treatment can reduce respiratory infections in children.

1 week ago
#3 STREPTOCOCCUS PYOGENES

Clinical trials investigating STREPTOCOCCUS PYOGENES are studying a treatment called PMBL (Ismigen) in children with respiratory tract infections.

1 week ago
#4 AZD1163

Clinical trials are investigating AZD1163 in adults with moderately to severely active rheumatoid arthritis.

1 week ago
#5 AZD5335

Clinical trials are investigating AZD5335 in women with advanced platinum-resistant epithelial ovarian cancer.

1 week ago
#6 IMB 101

Clinical trials are studying NAV-240 in adults with moderate-to-severe hidradenitis suppurativa.

1 week ago

Drugs starting by i

  • 8 

    Ixekizumab

    , , , ,

    Ixekizumab, also known by its brand name Taltz, is a monoclonal antibody that targets interleukin-17A (IL-17A). This drug is being studied in clinical trials for various conditions beyond its current approved uses. These trials aim to evaluate the safety, efficacy, and potential new applications of ixekizumab in treating different diseases, ranging from rare skin conditions to mental health disorders.

    Related diseases and areas:

  • 1 

    Ixodes Ricinus Contact Phase Inhibitor

    ,

    The BIRCH study is a Phase IIa clinical trial investigating the safety, tolerability, and potential efficacy of Ixodes Ricinus Contact Phase Inhibitor (Ir-CPI) in adult patients with spontaneous intracerebral hemorrhage (ICH). This innovative drug is being tested as a potential treatment for brain bleeding, aiming to improve outcomes for patients with this serious condition.

    Related diseases and areas:

  • 6 

    Izaflortaucipir (18F)

    , , , , ,

    Izaflortaucipir (18F), also known as [18F]PI-2620, is an innovative radiotracer being studied in clinical trials for its potential to detect tau protein aggregates in the brain. This article explores how this compound is being used to investigate tau pathology in various neurodegenerative conditions, including Alzheimer’s disease, Down syndrome, and progressive supranuclear palsy. By enabling visualization of tau deposits through PET imaging, Izaflortaucipir (18F) may provide valuable insights into disease progression and aid in diagnosis and treatment monitoring.

    Related diseases and areas:

  • 3 

    Izokibep

    , , ,

    Izokibep is an innovative drug currently being studied in clinical trials for the treatment of several inflammatory conditions. This potent and selective inhibitor of interleukin-17A (IL-17A) is showing promise in addressing diseases such as hidradenitis suppurativa, psoriatic arthritis, and non-infectious uveitis. The ongoing trials aim to evaluate the efficacy, safety, and potential benefits of izokibep for patients suffering from these challenging conditions.

    Related diseases and areas:

  • 1 

    Izorlisib Mesilate

    ,

    This article discusses the ongoing clinical trials investigating the use of Izorlisib Mesilate, also known as MEN1611, in combination with eribulin for treating advanced breast cancer. The study focuses on patients with specific genetic alterations in PIK3CA and PTEN genes, targeting both triple-negative and HR-positive/HER2-negative metaplastic breast cancers. The trials aim to assess the efficacy and safety of this combination therapy in improving outcomes for patients with limited treatment options.

    Related diseases and areas: